@article{f34ad43b070040988bcfa38719bb651c,
title = "Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin",
keywords = "INTENSITY WARFARIN THERAPY, LONG-TERM, NONSURGICAL PATIENTS, ATRIAL-FIBRILLATION, PREVENTION, DISEASE, ANTICOAGULANTS, COMPLICATIONS, DEFINITION, THROMBOSIS",
author = "Paolo Prandoni and Lensing, {Anthonie W. A.} and Prins, {Martin H.} and Martin Gebel and Pap, {Akos F.} and Martin Homering and Rupert Bauersachs and Jan Beyer-Westendorf and Henri Bounameaux and Cohen, {Alexander T.} and Davidson, {Bruce L.} and {van Bellen}, Bonno and Peter Verhamme and Wells, {Philip S.} and Zhong Yuan and Bennett Levitan and Weitz, {Jeffrey I.}",
year = "2018",
month = aug,
day = "1",
doi = "10.1016/j.thromres.2018.06.009",
language = "English",
volume = "168",
pages = "121--129",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Science",
}